Predictors of type of vascular access in hemodialysis patients

JAMA

Volumn 276, Issue 16, 1996, Pages 1303-1308

  Hirth, Richard A ^a,c   Turenne, Marc N ^b   Woods, John D ^b   Young, Eric W ^b,d   Port, Friedrich K ^b,c,d   Pauly, Mark V ^e   Held, Philip J ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; SURGICAL APPROACH; SURGICAL RISK; TREATMENT OUTCOME; UNITED STATES; VASCULAR ACCESS; VEIN GRAFT;

EID: 0029993830     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.16.1303     Document Type: Article

References (49)

1. Fan PY, Schwab SJ. Vascular access: concepts for the 1990s. J Am Soc Nephrol. 1992;3:1-11.
2. Chazan JA, London MR, Pono LM. Long-term survival of vascular accesses in a large chronic hemodialysis population. Nephron. 1995;69:228-233.
3. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA. Hemodialysis vascular access morbidity in the United States. Kidney Int. 1993;43:1091-1096.
4. Windus DW. Permanent vascular access: a nephrologist's view. Am J Kidney Dis. 1993;21:457-471.
5. Brescia MJ, Cimino JE, Appel K, Hurwick BF. Chronic hemodialysis using venipuncture and a surgically created arteriovenous shunt. N Engl J Med. 1966;275:1089-1092.
6. Baker LD, Johnson JM, Goldfarb D. Expanded polytetrafluoroethylene (PTFE) subcutaneous arteriovenous conduit: an improved vascular access for hemodialysis. Trans ASAIO. 1976;22:382-387.
7. US Renal Data System. USRDS 1995 Annual Data Report. Bethesda, Md: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995.
8. Windus DW. The effect of comorbid conditions on hemodialysis access patency. Adv Ren Replace Ther. 1994;1:148-154.
9. Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM, Tilney NL. Vascular access for hemodialysis: patency rates and results of revision. Ann Surg. 1985;202:235-239.
10. Connall TP, Wilson SE. Vascular access for hemodialysis. In: Rutherford RB, ed. Vascular Surgery. Philadelphia, Pa: WB Saunders Co; 1995:1233-1244.
11. Albers FJ. Causes of hemodialysis access failure, Adv Ren Replace Ther. 1994;1:107-118.
12. McEwen DR. Arteriovenous fistula: vascular accesss for long-term hemodialysis. AORN J. 1994; 59:225-232.
13. Bennion RS, Wilson SE. Hemodialysis and vascular access. In: Moore WS, ed. Vascular Surgery: A Comprehensive Review. Philadelphia, Pa: WB Saunders Co; 1993:606-629.
14. Lundin AP. Prolonged survival on dialysis. In: Maher JF, ed. Replacement of Renal Function by Dialysis. Dordrecht, the Netherlands: Kluwer Academic Publishers; 1989:1133-1140.
15. Connolly JE, Brownell DA, Levine EF, McCart PM. Complications of renal dialysis procedures. Arch Surg. 1984;119:1325-1328.
16. Hurt AV, Batello-Cruz M, Skipper BJ, Teaf SR, Sterling WA. Bovine carotid artery heterografts versus polytetrafluoroethylene grafts: a prospective, randomized study. Am J Surg. 1983;146: 844-847.
17. Munda R, First MR, Alexander JW, Linnemann CC, Fidler JP, Kittur D. Polytetrafluoroethylene graft survival in hemodialysis. JAMA. 1983;249: 219-222.
18. Turenne MN, Strawderman RL, Woods JD, et al. Vascular access survival in hemodialysis patients. J Am Soc Nephrol. 1995 6:504. Abstract.
19. Coburn MC, Carney WI. Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg. 1994;20:896-902.
20. Goldwasser P, Avram MM, Collier JT, Michel MA, Gusik SA, Mittman N. Correlates of vascular access occlusion in hemodialysis. Am J Kidney Dis. 1994;24:785-794.
21. Riordan S, Frawley J, Gray L, Niesche J. Primary access surgery for long-term hemodialysis. Aust N Z J Surg. 1994;64:763-767.
22. Churchill DN, Taylor DW, Cook RJ, et al. Canadian Hemodialysis Morbidity Study. Am J Kidney Dis. 1992;19:214-234.
23. Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients: clinical, immonocytochemical, light and electron microscopic assessment. Circulation. 1989;80:1726-1736.
24. Zibari GB, Rohr MS, Landreneau MD, et al. Complications from permanent hemodialysis vascular access. Surgery. 1988;104:681-686.
25. Kherlakian GM, Roedersheimer LR, Arbaugh JJ, Newmark KJ, King LR. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am J Surg. 1986;152:238-243.
26. Winsett OER, Wolma FJ. Complications of vascular access for hemodialysis. South Med J. 1985; 78:513-517.
27. Jenkins AM, Buist TA, Glover SP. Medium-term follow-up of forty autogenous vein and forty polytetrafluoroethylene (Gore-Tex) grafts for vascular access. Surgery. 1980;88:667-672.
28. Brotman DN, Fandos L, Faust GR, Doscher W, Cohen JR. Hemodialysis graft salvage. J Am Coll Surg. 1994;178:431-434.
29. US Renal Data System. USRDS 1992 Annual Data Report. Bethesda, Md: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1992.
30. Held PJ, Carroll CE, Liska DW, Turenne MA, Port FK. Hemodialysis therapy in the United States: what is the dose and does it matter? Am J Kidney Dis. 1994;24:974-980.
31. US Renal Data System. USRDS 1996 Annual Data Report. Bethesda, Md: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1996.
32. Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int. 1996;50:550-556.
33. Greene WH. Econometric Analysis. 2nd ed. New York, NY: Macmillan Publishing Co Inc; 1993.
34. Young EW, Carroll CE, Wolfe RA, Port FK, Held PJ. Trends in comorbidity and residual renal function in patients starting treatment for endstage renal disease. J Am Soc Nephrol. 1995;6:569. Abstract.
35. Miller ME, Holahan J, Welch WP. Geographic variations in physician service utilization. Med Care Res Rev. 1995;52:252-278.
36. Wennberg JE, Gittelsohn A. Small area variations in health care delivery. Science. 1973;182:1102-1108.
37. Holahan J, Dor A, Zuckerman S. Area variations in selected Medicare procedures. Health Aff (Millwood). 1990;9:166-176.
38. Phelps CE. Diffusion of information in medical care. J Econ Perspect. 1992;6:23-42.
39. McMahon LF, Wolfe RA, Tedeschi PJ. Variation in hospital admissions among small areas: a comparison of Maine and Michigan. Med Care. 1989; 27:623-631.
40. McLaughlin CG, Normolle DP, Wolfe RA, McMahon LF, Griffith JR. Small area variations in hospital discharge rates: do socioeconomic variables matter? Med Care. 1989;5:507-521.
41. Phelps CE, Parente ST. Priority setting for medical technology and medical practice assessment. Med Care. 1990;28:703-723.
42. Wennberg JE, Freeman JL, Shelton RM, Bubolz TA. Are hospital services rationed in New Haven or over-utilized in Boston? Lancet. 1987;1: 1185-1189.
43. Bleyer AJ, Disney AP, Hylander B, et al. The multinational study of dialysis therapy: hemodialysis access. J Am Soc Nephrol. 1995;6:483. Abstract.
44. Jensen BV, Vestersgaard-Andersen TB, Nielsen PH. Arteriovenous shunts used in hemodialysis: a retrospective study of the results in 86 patients treated during a 5 year period. Ugeskr Laeger. 1990;152:2169-2171.
45. Wehrli H, Chenevard R, Zaruba K. Surgical experiences with the arteriovenous hemodialysis shunt (1970-1988). Helv Chir Acta. 1989;56:621-627.
46. Windus DW, Jendrisak MD, Delmez JA. Prosthetic fistula survival and complications in hemodialysis patients: effects of diabetes and age. Am J Kidney Dis. 1992;19:448-452.
47. Sommer BG, Sumrani NB, Hong JH. Current strategies for vascular access in patients on hemodialysis. ASAIO J. 1992;38:743-744.
48. Prischl FC, Kirchgatterer A, Brandstatter E, et al. Parameters of prognostic relevance to the patency of vascular access in hemodialysis patients. J Am Soc Nephrol. 1995;6:1613-1618.
49. Sands JJ, Miranda CL. Increasing AV fistulas for hemodialysis access. J Am Soc Nephrol. 1995; 6:501. Abstract.